Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Transactions
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Asset disposition
Quarterly results
Acq. announced
CC transcript
Employment agrmnt
Coll. bargaining agrmnt
Director departure
NOVELION THERAPEUTICS INC. (NVLNF) Create: Alert

All | News | Filings
Date FiledTypeDescription
01/03/2020 8-K Quarterly results
12/05/2016 8-K Form 8-K - Current report
03/21/2016 8-K Asset disposition
Docs: "About QLT QLT is a biotechnology company dedicated to the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. We are focused on developing our synthetic retinoid program for the treatment of certain inherited retinal diseases. QLT's head office is based in Vancouver, Canada and the Company is publicly traded on NASDAQ Stock Market and the Toronto Stock Exchange . For more information about the Company's products and developments, please visit our website at www.qltinc.com. Cautionary Statement Regarding Forward-Looking Statements Certain statements in this press release constitute “forward-looking statements” of QLT within the meaning of the Private Securities Litigation Reform Act of 1995 and constitute..."
08/01/2013 8-K Form 8-K - Current report
04/04/2013 8-K Asset disposition
Docs: "Press Release"
09/24/2012 8-K Form 8-K - Current report
10/06/2009 8-K Form 8-K - Current report
12/22/2006 8-K Form 8-K - Current report

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy